Compile Data Set for Download or QSAR
maximum 50k data
Found 526 with Last Name = 'gauuan' and Initial = 'j'
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377655(CHEMBL260160)
Affinity DataKi:  0.00500nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377635(CHEMBL402980)
Affinity DataKi:  0.0130nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377637(CHEMBL257398)
Affinity DataKi:  0.0280nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377629(CHEMBL260086)
Affinity DataKi:  0.0470nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50328717(5-Chloro-N-(5-chloro-pyridin-2-yl)-3-methoxy-2-[4-...)
Affinity DataKi:  0.0570nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377638(CHEMBL257400)
Affinity DataKi:  0.0600nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377628(CHEMBL261536)
Affinity DataKi:  0.0650nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM19023(1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-y...)
Affinity DataKi:  0.0800nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377640(CHEMBL258196)
Affinity DataKi:  0.120nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377656(CHEMBL259534)
Affinity DataKi:  0.140nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377631(CHEMBL256152)
Affinity DataKi:  0.140nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377636(CHEMBL257399)
Affinity DataKi:  0.140nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377630(CHEMBL404448)
Affinity DataKi:  0.190nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377643(CHEMBL257966)
Affinity DataKi:  0.210nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377627(CHEMBL260369)
Affinity DataKi:  0.240nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377632(CHEMBL404449)
Affinity DataKi:  0.330nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377633(CHEMBL403075)
Affinity DataKi:  0.450nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377646(CHEMBL259535)
Affinity DataKi:  0.580nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377641(CHEMBL402836)
Affinity DataKi:  0.620nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377647(CHEMBL411044)
Affinity DataKi:  1nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377652(CHEMBL256573)
Affinity DataKi:  1.10nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377650(CHEMBL260354)
Affinity DataKi:  1.20nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377644(CHEMBL1162978)
Affinity DataKi:  1.30nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377634(CHEMBL428432)
Affinity DataKi:  2nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377639(CHEMBL258188)
Affinity DataKi:  2.20nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377649(CHEMBL260912)
Affinity DataKi:  3nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377642(CHEMBL257967)
Affinity DataKi:  4.20nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377653(CHEMBL402761)
Affinity DataKi:  5.5nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377648(CHEMBL260911)
Affinity DataKi:  43nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377654(CHEMBL256574)
Affinity DataKi:  59nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377645(CHEMBL259533)
Affinity DataKi:  1.56E+3nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50007296(CHEMBL3238246)
Affinity DataKi:  2.43E+3nMAssay Description:Binding affinity to adenosine A3 receptor (unknown origin) by agonist displacement assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development

Curated by ChEMBL
LigandPNGBDBM50377651(CHEMBL404745)
Affinity DataKi:  7.67E+3nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLymphokine-activated killer T-cell-originated protein kinase(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM148993(US8962648, 72 | US8962648, 73)
Affinity DataIC50:  0.380nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLymphokine-activated killer T-cell-originated protein kinase(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM149054(US8962648, 319)
Affinity DataIC50:  0.430nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLymphokine-activated killer T-cell-originated protein kinase(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM149042(US8962648, 276)
Affinity DataIC50:  0.5nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLymphokine-activated killer T-cell-originated protein kinase(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM149041(US8962648, 275)
Affinity DataIC50:  0.540nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLymphokine-activated killer T-cell-originated protein kinase(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM149027(US8962648, 235)
Affinity DataIC50:  0.570nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLymphokine-activated killer T-cell-originated protein kinase(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM148993(US8962648, 72 | US8962648, 73)
Affinity DataIC50:  0.630nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLymphokine-activated killer T-cell-originated protein kinase(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM149118(US8962648, 1160)
Affinity DataIC50:  0.640nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLymphokine-activated killer T-cell-originated protein kinase(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM149043(US8962648, 277)
Affinity DataIC50:  0.670nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLymphokine-activated killer T-cell-originated protein kinase(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM149016(US8962648, 195)
Affinity DataIC50:  0.730nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLymphokine-activated killer T-cell-originated protein kinase(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM149039(US8962648, 273)
Affinity DataIC50:  0.740nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLymphokine-activated killer T-cell-originated protein kinase(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM149192(US8962648, 1309)
Affinity DataIC50:  0.740nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLymphokine-activated killer T-cell-originated protein kinase(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM149034(US8962648, 266)
Affinity DataIC50:  0.780nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLymphokine-activated killer T-cell-originated protein kinase(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM148997(US8962648, 84)
Affinity DataIC50:  0.780nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLymphokine-activated killer T-cell-originated protein kinase(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM149026(US8962648, 233)
Affinity DataIC50:  0.810nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLymphokine-activated killer T-cell-originated protein kinase(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM149062(US8962648, 336)
Affinity DataIC50:  0.820nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLymphokine-activated killer T-cell-originated protein kinase(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM149097(US8962648, 1120)
Affinity DataIC50:  0.880nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLymphokine-activated killer T-cell-originated protein kinase(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM149038(US8962648, 272)
Affinity DataIC50:  0.880nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 526 total ) | Next | Last >>
Jump to: